COVID-associated non-vasculitic thrombotic retiform purpura of the face and extremities: A case report

Date
2022-12-27
Language
American English
Embargo Lift Date
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Wiley
Can't use the file because of accessibility barriers? Contact us with the title of the item, permanent link, and specifics of your accommodation need.
Abstract

SARS-CoV-2 infection can manifest many rashes. However, thrombotic retiform purpura rarely occurs during COVID-19 illness. Aggressive anti-COVID-19 therapy with a high-dose steroid regimen led to rapid recovery. This immunothrombotic phenomenon likely represents a poor type 1 interferon response and complement activation on the endothelial surface in response to acute infection.

Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Bunch CM, Zackariya N, Thomas AV, et al. COVID-associated non-vasculitic thrombotic retiform purpura of the face and extremities: A case report. Clin Case Rep. 2022;10(12):e6790. Published 2022 Dec 27. doi:10.1002/ccr3.6790
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Clinical Case Reports
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Version
Final published version
Full Text Available at
This item is under embargo {{howLong}}